stockrow
Friday 6 November 2026
Export ARAY’s income statement to Excel — free account
Accuray Incorporated
ARAY Healthcare Medical Devices
Accuray Incorporated’s revenue for fiscal 2026 (year ended June 2026) was $401.9 million, down 12.3% from fiscal 2025.
- Revenue
- −7.90%
- EPS
- +138.9%
- Free cash flow
- −138.3%
- Total debt
- −25.4%
Quarter to September 2026, against a year earlier
0.11
0.01
−8.33%
Follow ARAY
Alert me
Accuray Incorporated (ARAY) P/E ratio
Accuray Incorporated has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 182× (April 2025) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 0.0× | — |
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 67.7× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 0.0× | — |
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| 43 more quarters | Free account |
Against its own ten years
Low 0.0×
High 182×
Ten-year median
0.0×
Current reading's percentile
87
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| PAVM PAVmed Inc. compare | n/m |
| PETV PetVivo Holdings, Inc. compare | n/m |
| CTSO Cytosorbents Corporation compare | n/m |
| ALUR Allurion Technologies, Inc. compare | n/m |
| HSCS HeartSciences Inc. compare | n/m |
| RBOT Vicarious Surgical Inc. compare | n/m |
| LFWD Lifeward Ltd. compare | n/m |
| ARAY Accuray Incorporated | n/m |
| ITOC iTonic Holdings Ltd. compare | — |
| Medical Devices industry median | 24.9× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)